This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Drug Pricing Transparency Congress
2023 Dates TBD

Mark Scallon
Partner at Baker Tilly US


Mark Scallon has more than 20 years’ experience working with clients in the life sciences industry to transform their compliance function. Mark joined Baker Tilly in January 2020 as a principal in the life sciences practice. He has particular knowledge in compliance program development, process design, compliance auditing and monitoring, risk assessments, global spend transparency reporting, global investigations, privacy, pricing, and anti-bribery and corruption. Over the last 20+ years, Mark has assisted life science organizations with identifying existing and emerging compliance risks to develop practical solutions aligning company policies and procedures with industry practices, guidelines, regulations and laws.

Agenda Sessions

  • State Drug Price Transparency Tools and Strategies to Ensure Operational Readiness


Speakers at this event